Ingalls Memorial Hospital; Cancer Research Center
Harvey, Illinois 64026
0 studies enrolling now · 3 studies all time
What they study most
Colorectal Cancer, Metastatic Pancreatic Adenocarcinoma, Multiple Myeloma
Studies at this site
- Multiple Myeloma Patient Registry — Stopped early
- Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE) — Completed
- FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer — Completed